These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36584785)

  • 1. High incidence of clinical fragility fractures in postmenopausal women with rheumatoid arthritis. A case-control study.
    Gómez-Vaquero C; Hernández JL; Olmos JM; Cerdà D; Calleja CH; López JAM; Arboleya L; Del Rey FJA; Pardo SM; Vilamajó IR; Armangué XS; Grados D; Audera CB; Suero-Rosario E; Gracia IG; Chamizo AS; Martín-Esteve I; Florez H; Naranjo A; Castañeda S; Bruno SO; Carazo SG; Garcia-Vadillo A; Vives LL; Martínez-Ferrer À; Paños HB; Acín PA; Castellanos-Moreira R; Satorra P; Tebé C; Guañabens N;
    Bone; 2023 Mar; 168():116654. PubMed ID: 36584785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between 10-year fracture risk by FRAX and osteoporotic fractures with disease activity in patients with rheumatoid arthritis.
    Phuan-Udom R; Lektrakul N; Katchamart W
    Clin Rheumatol; 2018 Oct; 37(10):2603-2610. PubMed ID: 30039267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trabecular bone score as a supplementary tool for the discrimination of osteoporotic fractures in postmenopausal women with rheumatoid arthritis.
    Choi YJ; Chung YS; Suh CH; Jung JY; Kim HA
    Medicine (Baltimore); 2017 Nov; 96(45):e8661. PubMed ID: 29137106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vertebral fractures are increased in rheumatoid arthritis despite recent therapeutic advances: a case-control study.
    Guañabens N; Olmos JM; Hernández JL; Cerdà D; Hidalgo Calleja C; Martinez López JA; Arboleya L; Aguilar Del Rey FJ; Martinez Pardo S; Ros Vilamajó I; Suris Armangué X; Grados D; Beltrán Audera C; Suero-Rosario E; Gómez Gracia I; Salmoral Chamizo A; Martín-Esteve I; Florez H; Naranjo A; Castañeda S; Ojeda Bruno S; García Carazo S; García Vadillo A; López Vives L; Martínez-Ferrer À; Borrell Paños H; Aguado Acín P; Castellanos-Moreira R; Tebé C; Gómez-Vaquero C;
    Osteoporos Int; 2021 Jul; 32(7):1333-1342. PubMed ID: 33459805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Serum sRANKL, sRANKL/OPG Ratio, and Other Bone Turnover Markers with the Estimated 10-Year Risk of Major and Hip Osteoporotic Fractures in Rheumatoid Arthritis: A Cross-Sectional Study.
    Nava-Valdivia CA; Ponce-Guarneros JM; Saldaña-Cruz AM; Corona-Sanchez EG; Ramirez-Villafaña M; Perez-Guerrero EE; Murillo-Saich JD; Contreras-Haro B; Vazquez-Villegas ML; Gonzalez-Ponce F; Bonilla-Lara D; Jacobo-Cuevas H; Centeno-Valadez JD; Echeverria-Gonzalez G; Cerpa-Cruz S; Alcaraz-Lopez MF; Cardona-Muñoz EG; Salazar-Paramo M; Gonzalez-Lopez L; Gamez-Nava JI
    Biomed Res Int; 2021; 2021():5567666. PubMed ID: 34497849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study.
    Abtahi S; Driessen JHM; Burden AM; Souverein PC; van den Bergh JP; van Staa TP; Boonen A; de Vries F
    Ann Rheum Dis; 2021 Apr; 80(4):423-431. PubMed ID: 33310727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year incidences of self-reported non-vertebral fractures in Japanese patients with rheumatoid arthritis: discrepancy between disease activity control and the incidence of non-vertebral fracture.
    Ochi K; Inoue E; Furuya T; Ikari K; Toyama Y; Taniguchi A; Yamanaka H; Momohara S
    Osteoporos Int; 2015 Mar; 26(3):961-8. PubMed ID: 25294026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of advanced glycation end products in fracture risk assessment in postmenopausal type 2 diabetic patients.
    Gao L; Liu C; Hu P; Wang N; Bao X; Wang B; Wang K; Li Y; Xue P
    Front Endocrinol (Lausanne); 2022; 13():1013397. PubMed ID: 36578954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of fractures among patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Jin S; Hsieh E; Peng L; Yu C; Wang Y; Wu C; Wang Q; Li M; Zeng X
    Osteoporos Int; 2018 Jun; 29(6):1263-1275. PubMed ID: 29546507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating osteoporotic fracture risk with the Fracture Risk Assessment Tool in Chinese patients with rheumatoid arthritis.
    Meng J; Li Y; Yuan X; Lu Y
    Medicine (Baltimore); 2017 May; 96(18):e6677. PubMed ID: 28471962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density.
    Klop C; de Vries F; Bijlsma JW; Leufkens HG; Welsing PM
    Ann Rheum Dis; 2016 Dec; 75(12):2095-2100. PubMed ID: 26984006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for vertebral fracture in menopausal or postmenopausal Japanese women with rheumatoid arthritis: a cross-sectional and longitudinal study.
    Arai K; Hanyu T; Sugitani H; Murai T; Fujisawa J; Nakazono K; Kondo N; Endo N
    J Bone Miner Metab; 2006; 24(2):118-24. PubMed ID: 16502118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factor analysis of fragility fractures in rheumatoid arthritis: A 3-year longitudinal, real-world, observational, cohort study.
    Lin PH; Yu SF; Chen JF; Chen YC; Lai HM; Chiu WC; Hsu CY; Wang YW; He HR; Chen YY; Cheng CY; Cheng TT
    PLoS One; 2021; 16(8):e0255542. PubMed ID: 34347843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fracture distribution in postmenopausal women: a FRISBEE sub-study.
    Aude M; Jean-Jacques B; Laura I; Felicia B; Alexia C; Serge R; Mureille S; Pierre B; Florence B
    Arch Osteoporos; 2022 Dec; 18(1):3. PubMed ID: 36469184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid arthritis patients with hip fracture: a nationwide study.
    Lin YC; Li YH; Chang CH; Hu CC; Chen DW; Hsieh PH; Lee MS; Ueng SW; Chang Y
    Osteoporos Int; 2015 Feb; 26(2):811-7. PubMed ID: 25410437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year fracture risk by FRAX and osteoporotic fractures in patients with systemic autoimmune diseases.
    Lai EL; Huang WN; Chen HH; Hsu CY; Chen DY; Hsieh TY; Hung WT; Lin CT; Lai KL; Tang KT; Chen YM; Chen YH
    Lupus; 2019 Jul; 28(8):945-953. PubMed ID: 31177913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors predicting the 'time to first fracture' and its association with imminent fractures: a substudy of the FRISBEE cohort.
    de Filette JMK; Charles A; Bellanger A; Iconaru L; Baleanu F; Surquin M; Body JJ; Bergmann P
    Arch Osteoporos; 2023 Jun; 18(1):88. PubMed ID: 37369953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis and fractures in rheumatoid arthritis.
    Wysham KD; Baker JF; Shoback DM
    Curr Opin Rheumatol; 2021 May; 33(3):270-276. PubMed ID: 33651725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic disease-modifying anti-rheumatic drugs and the risk of non-vertebral osteoporotic fractures in patients with rheumatoid arthritis aged 50 years and over.
    Roussy JP; Bessette L; Bernatsky S; Rahme E; Lachaine J
    Osteoporos Int; 2013 Sep; 24(9):2483-92. PubMed ID: 23504029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk factors associated with vertebral osteoporotic fractures in patients with rheumatoid arthritis.
    Tong JJ; Xu SQ; Zong HX; Pan MJ; Teng YZ; Xu JH
    Clin Rheumatol; 2020 Feb; 39(2):357-364. PubMed ID: 31691041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.